A collaborative investigation by researchers at Brigham and Women's Hospital and Johns Hopkins University created a cancer treatment that utilizes mesenchymal stem cells and microparticles. Both components of the treatment are engineered to specifically target and kill cancer cells.
Topics: bioengineering, tumors, chemotherapy, Cancer, StemSave blog, mesenchymal stem cells, microparticles
AAOMS - American Association of Oral and Maxillofacial Surgeons
As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.
